Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
W.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.250NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.1.130NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.315NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.1.204NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.170NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.232NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.84NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.301NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.269NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.323NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.105 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.9 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.398NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.94 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.10 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.41 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.71NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.142NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.166NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.11 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.34.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.234NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Z.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
V.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.282NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.131NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.274NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used